Haemonetics (HAE) Inventory (2010 - 2026)

Haemonetics has reported Inventory for 17 years, with the latest figure at $306.7 million in Q2 2026.

• On a quarterly basis, Inventory fell 14.92% year-over-year to $306.7 million in Q2 2026; TTM through Jun 2026 was $306.7 million, a 14.92% decrease from a year earlier, with the FY2026 full-year figure at $306.4 million, down 16.1% from the prior year.
• Inventory was $306.7 million for Q2 2026 at Haemonetics, roughly flat from $306.4 million in the prior quarter.
• The five-year high for Inventory was $382.1 million in Q3 2024, with the low at $254.7 million in Q4 2022.
• Average Inventory over 5 years is $313.4 million, with a median of $306.4 million recorded in 2026.
• The sharpest annual moves came in 2022 and 2024: Inventory dropped 21.07% in 2022, then soared 33.68% in 2024.
• Over 5 years, Inventory stood at $255.8 million in 2022, then increased by 18.87% to $304.0 million in 2023, then advanced by 18.28% to $359.6 million in 2024, then retreated by 10.69% to $321.2 million in 2025, then retreated by 4.5% to $306.7 million in 2026.
• The last three Inventory figures came in at $306.7 million (Q2 2026), $306.4 million (Q1 2026), and $321.2 million (Q4 2025), per Business Quant data.